Journal of Antimicrobial Chemotherapy 2003-09-01

Differentiation of genotypic resistance profiles for amprenavir and lopinavir, a valuable aid for choice of therapy in protease inhibitor-experienced HIV-1-infected subjects.

Denise Paulsen, Robert Elston, Wendy Snowden, Margaret Tisdale, Lisa Ross

Index: J. Antimicrob. Chemother. 52(3) , 319-23, (2003)

Full Text: HTML

Abstract

Structure	Name/CAS No.	Molecular Formula	Articles
	Amprenavir CAS:161814-49-9	C₂₅H₃₅N₃O₆S

A comparison of in vitro ADME properties and pharmacokinetic...
2014-12-01
[Eur. J. Drug Metab. Pharmacokinet. 39(4) , 263-76, (2014)]

Parallel ultra high pressure liquid chromatography-mass spec...
2014-08-15
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 965 , 244-53, (2014)]

HZ08 reverse P-glycoprotein mediated multidrug resistance in...
2015-01-01
[PLoS ONE 10(2) , e0116886, (2015)]

Extreme multidrug resistant HIV-1 protease with 20 mutations...
2013-05-23
[J. Med. Chem. 56(10) , 4017-27, (2013)]

Suppression of pre adipocyte differentiation and promotion o...
2012-01-01
[In Vivo 26(2) , 287-91, (2012)]

Differentiation of genotypic resistance profiles for amprenavir and lopinavir, a valuable aid for choice of therapy in protease inhibitor-experienced HIV-1-infected subjects.

Abstract

Related Compounds